CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleMarket cap is $48.13B, higher than 95% of all stocks globally
- PositionReturn on equity is 19.9%, higher than 95% of its Scientific & Technical Instruments peers (median 4.8%)
- Interpretations12 currently firing — 12
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.68%Below 5Y avg (2.08%)
Annual Rate
USD 4.20Paid quarterly
Payout Ratio
40.2%Sustainable
Consecutive Growth
8 yr
Paying Dividends
23 yr
Payback Period
78.7 yr
Next Ex-Dividend
Sep 11, 2026
Next Payment
Mar 26, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
48.13BUSDvs all stocks (USD)
Trailing P/E
26.96xvs Scientific & Technical Instruments peers
Revenue (TTM)
7.46BUSDvs all stocks (USD)
Profit Margin
23.26%vs Scientific & Technical Instruments peers
Beta
0.9140xvs all stocks
52-Week Change
10.35%vs all stocks
Forward Annual Dividend Yield
1.68%vs all stocks
Market Capitalization
48.13BUSDvs all stocks (USD)
Enterprise Value
45.92BUSDvs all stocks (USD)
Trailing P/E
26.96xvs Scientific & Technical Instruments peers
Forward P/E
24.31xvs Scientific & Technical Instruments peers
PEG Ratio
1.26xPrice to Sales (TTM)
6.49xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
5.22xvs Scientific & Technical Instruments peers
Enterprise to Revenue
6.15xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
21.20xvs Scientific & Technical Instruments peers
Gross Margin
59.44%vs Scientific & Technical Instruments peers
Profit Margin
23.26%vs Scientific & Technical Instruments peers
Operating Margin
24.62%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
11.90%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
19.90%vs Scientific & Technical Instruments peers
Revenue (TTM)
7.46BUSDvs all stocks (USD)
Revenue per Share (TTM)
38.77USDUpdated Jul 19, 2026Quarterly Revenue Growth
14.20%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
4.41BUSDvs all stocks (USD)
EBITDA (TTM)
2.18BUSDvs all stocks (USD)
Net Income (TTM)
1.74BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.70%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
1.75BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
810.16MUSDvs all stocks (USD)
Forward Annual Dividend Rate
4.20USDUpdated Jul 19, 2026Forward Annual Dividend Yield
1.68%vs all stocks
Trailing Annual Dividend Rate
3.75USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
1.50%vs all stocks
5-Year Average Dividend Yield
2.08%vs all stocks
Payout Ratio
40.18%vs Scientific & Technical Instruments peers
Revenue
7.25BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
2.99BUSDFY2025 · Dec 31, 2025Gross Profit
4.26BUSDFY2025 · Dec 31, 2025Operating Income
1.88BUSDvs all stocks (USD)
Pre-tax Income
2.01BUSDFY2025 · Dec 31, 2025Income Tax Expense
350.65MUSDFY2025 · Dec 31, 2025Net Income
1.66BUSDFY2025 · Dec 31, 2025EBIT
1.88BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.06BUSDFY2025 · Dec 31, 2025Research & Development
1.13BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.25BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
128.87MUSDFY2025 · Dec 31, 2025EPS (Basic)
8.65USDFY2025 · Dec 31, 2025EPS (Diluted)
8.59USDFY2025 · Dec 31, 2025Basic Shares Outstanding
192.47MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
192.47MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.66BUSDFY2025 · Dec 31, 2025Operating Cash Flow
1.67BUSDFY2025 · Dec 31, 2025Free Cash Flow
1.40BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.28BUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.66BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
188.76MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
82.55MUSDFY2025 · Dec 31, 2025Stock-based Compensation
166.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-222.81MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-30.52MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-180.12MUSDFY2025 · Dec 31, 2025Capital Expenditures
-270.45MUSDFY2025 · Dec 31, 2025Net Acquisitions
-175.66MUSDFY2025 · Dec 31, 2025Purchase of Investments
-839.85MUSDFY2025 · Dec 31, 2025Sale of Investments
640.40MUSDFY2025 · Dec 31, 2025Other Investing Activity
322.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-645.24MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-181.01MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-663.88MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-844.90MUSDFY2025 · Dec 31, 2025Shares Outstanding
192.90MSharesUpdated Jul 19, 2026Float Shares
164.62MSharesUpdated Jul 19, 2026Shares Short
4.16MSharesUpdated Jul 19, 2026Short Ratio
4.66daysvs all stocks
Short % of Shares Outstanding
2.53%vs all stocks
% Held by Insiders
14.70%vs all stocks
% Held by Institutions
58.53%vs all stocks
Total Cash (MRQ)
2.70BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
14.01USDUpdated Jul 19, 2026Total Debt (MRQ)
216.11MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0233xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
4.36xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
48.06USDUpdated Jul 19, 2026Total Assets
10.99BUSDvs all stocks (USD)
Total Current Assets
6.25BUSDFY2025 · Dec 31, 2025Total Liabilities
2.02BUSDFY2025 · Dec 31, 2025Total Non-current Assets
4.75BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
301.03MUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.72BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.28BUSDFY2025 · Dec 31, 2025Other Short-term Investments
459.20MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.25BUSDFY2025 · Dec 31, 2025Inventory
1.77BUSDFY2025 · Dec 31, 2025Accounts Payable
347.49MUSDFY2025 · Dec 31, 2025Deferred Revenue
105.65MUSDFY2025 · Dec 31, 2025Long-term Debt
164.84MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
625.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
19.49MUSDFY2025 · Dec 31, 2025Retained Earnings
6.97BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
8.97BUSDvs all stocks (USD)
Treasury Stock
406.42MUSDFY2025 · Dec 31, 202552-Week Low
186.67USDUpdated Jul 19, 202652-Week High
273.32USDUpdated Jul 19, 202652-Week Change
10.35%vs all stocks
Beta
0.9140xvs all stocks
50-Day MA
237.98USDUpdated Jul 19, 2026200-Day MA
229.11USDUpdated Jul 19, 2026Avg 10-Day Volume
649.32KSharesUpdated Jul 19, 2026Avg 30-Day Volume
816.13KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
9.31USDUpdated Jul 19, 2026Other Income / Expense
9.59MUSDFY2025 · Dec 31, 202512 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 19.9%, higher than 95% of its Scientific & Technical Instruments peers (median 4.8%)Significant
Return on equity: 0.20Industry median: 0.05Industry P95: 0.18Peers compared: 32.00
Return on assets is 11.9%, higher than 95% of its Scientific & Technical Instruments peers (median 3.3%)Significant
Return on assets: 0.12Industry median: 0.03Industry P95: 0.12Peers compared: 32.00
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Market cap is $48.13B, higher than 95% of all stocks globallySignificant
Market cap (USD): 48,129,194,769Global P95: 25,614,208,870.135
Revenue is $7.46B, above the global median of $520.53MNotable
Revenue (USD): 7,463,908,864Global Median: 520,528,949.311
Levered free cash flow is $810.16M, above the global median of $16.24MNotable
Levered free cash flow (USD): 810,156,096Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Lonza Group AG
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Nan Ya Plastics Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Compagnie de Saint-Gobain S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Teradyne, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Mercedes-Benz Group AG
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shengyi Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Maruti Suzuki India Limited
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Tdk Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rockwell Automation, Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Suzhou TFC Optical Communication Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
11 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios ElevatedMulti-Year FCF With Growth And Margin
Catalyst Pharmaceuticals Inc.
12 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios ElevatedMulti-Year FCF With Growth And Margin
NVIDIA Corporation
12 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios ElevatedMulti-Year FCF With Growth And Margin